![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 19, 2020 7:29:44 PM
1. When will we receive the translational data? Does the higher dose of Gen-1 result in higher levels of IL-12, interferon g, dendritic cells, memory T cells, and CD8+ and CD4+ in tumor? Does it increase the decrease in immunosuppressive biomarkers?
2. What is the FDA saying? Can we expect some form of expedited approval?
3. Is there partnering interest in Gen-1?....as there is in Thermodox? Might a large Pharma be interested in both?
"The refusal of the real is the number one dogma of our time" Rene Girard
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM